The selling stockholders may offer and resell from time to time up to 50M shares of common stock of Unicycive Therapeutics. The company is not selling any common stock under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNCY:
- Unicycive Therapeutics joins Russell Microcap Index
- Unicycive Therapeutics Joins Russell Microcap® Index
- Unicycive Therapeutics Reports Clinical Trial Breakthrough
- Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
- Unicycive Therapeutics achieves study objective in OLC clinical trial